AGA I-SEE App
AGA I-SEE App is a clinical severity calculator for Eosinophilic Esophagitis, designed for gastroenterology and allergy specialists on iOS and Android.
The App DNA
What makes this app unique?
It removes the cognitive friction of manual points-based clinical scoring during patient consultations, providing a standardized, evidence-based assessment tool at the point of care.
For Healthcare professionals including gastroenterologists and allergy/immunology specialists managing patients with Eosinophilic Esophagitis.
What does it look like?
Key features
Points-based assessment tool for Eosinophilic Esophagitis severity. Revenue Link: Brand authority; reinforces the American Gastroenterological Association's status as the primary clinical resource for GI professionals.
Detailed information regarding EoE condition features and severity criteria. Revenue Link: B2B/Partnership; provides value-add to AGA members, supporting the membership retention loop.
Calculation module for food-related impact scores in EoE cases. Revenue Link: null
How much does it cost?
The app is provided as a free utility by the American Gastroenterological Association to support clinical practice and professional standards.
Velocity
Dormant developmentperformanceShow more...
The app has been inactive for 537 days, falling well outside the threshold for active development. The last release was a minor update focused on correcting a calculation error within the app. There is no evidence of ongoing feature development, live operations, or maintenance cycles. The development momentum is currently stagnant.
Who built it?
American Gastroenterological Association
2 apps tracked · Medical
AGA MASH AppUser Sentiment
What do users think recently?
How are ratings & reviews evolving?
Not enough recent reviews to extract reliable themes yet.
Read the full review analysisCompetition
Competitive landscape for AGA I-SEE App
How's the Medical market?
AGA I-SEE App occupies a niche as a free, professional-grade clinical utility. It maintains a 5-star rating on iOS, though the 17-month update gap signals a lack of active market expansion.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for AGA I-SEE App
Where is it heading?
The clinical utility market is shifting toward integrated, multi-platform management suites that connect clinician tools with patient-reported outcomes. AGA I-SEE App remains a static reference tool, leaving it vulnerable to more agile, updated clinical platforms that offer broader diagnostic support.
- The 17-month development silence suggests the app is in maintenance mode, which limits its ability to adapt to evolving clinical EoE standards.
- The lack of recent feature expansion creates a gap for competitors to offer more integrated, multi-platform clinical management tools.
The SWOT
- Digital integration of clinical guidelines reinforces the American Gastroenterological Association's authority as the primary clinical resource for GI professionals.
- Integration of patient-facing symptom tracking could expand the utility from a clinician-only tool to a comprehensive EoE management platform.
Next best moves
Audit calculation logic because the app has been silent for 17 months → ensure clinical accuracy
The counter-intuitive read
The app's lack of updates is not just a maintenance failure…
Read the full takeBottom line
AGA I-SEE App serves as a stable, authoritative reference tool for clinicians, but the lack of recent feature investment risks its long-term utility. Prioritizing a technical audit would ensure the calculation logic remains accurate, protecting the American Gastroenterological Association's professional reputation.
Unlock 1 critical friction, 1 market threat and the analyst’s take.
Access the full report for freeSources
- [1] App Store
Report last updated